Debbie Gibbs
Family Medicine · Washington, IANPI 1902863558
Payments from drug & device makers
Across 97 payments — averaging $12.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$398
- Pfizer$182
- AstraZeneca$168
- Amgen$89
- AbbVie$52
- Johnson & Johnson$47
- plus $313 from 16 others
What the payments were for
- Food & beverage$1,248100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 28 | $398 |
| Pfizer | 28 | $182 |
| AstraZeneca | 4 | $168 |
| Amgen | 6 | $89 |
| AbbVie(2 entities) | 3 | $52 |
| Johnson & Johnson | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $46 |
| GSK | 3 | $37 |
| Novo Nordisk | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $25 |
| Astellas Pharma US Inc | 2 | $24 |
| Boehringer Ingelheim | 2 | $23 |
| Tris Pharma Inc | 1 | $17 |
| Merck | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Novartis | 1 | $11 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$124
How this compares
$1,248 in reported general payments places this provider in the 80th percentile of 1,357 family medicine providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 61 | $44,679 |
| JardianceEmpagliflozin | 37 | $42,639 |
| OzempicSemaglutide | 32 | $31,207 |
| MyrbetriqMirabegron | 33 | $13,144 |
| KerendiaFinerenone | 14 | $10,666 |
| Spiriva HandihalerTiotropium Bromide | 11 | $10,141 |
| LinzessLinaclotide | 18 | $9,458 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $8,325 |
| TradjentaLinagliptin | 12 | $8,169 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 11 | $2,416 |
| Bupropion XlBupropion Hcl | 115 | $2,352 |
| Levothyroxine Sodium | 300 | $2,249 |
| Potassium Chloride | 94 | $2,172 |
| Varenicline Tartrate | 16 | $2,057 |
| Omeprazole | 184 | $1,964 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $23 | $50,80849 claims |
| PfizerEliquis | $182 | $44,67961 claims |
| Novo NordiskOzempic | $26 | $31,20732 claims |
| Astellas Pharma US IncMyrbetriq | $24 | $13,14433 claims |
| AbbVieLinzess | $52 | $9,45818 claims |
| GSKTrelegy Ellipta | $37 | $8,32512 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $12 | $2,249300 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,357 family medicine providers in Iowa.
Other family medicine in Washington
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
- Thomas RossDes Moines$170K
- Yogesh ShahDes Moines$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.